Managing patients on direct factor Xa inhibitors with rapid thrombelastography.
Sign Up to like & getrecommendations! Published in 2021 at "Scandinavian journal of clinical and laboratory investigation"
DOI: 10.1080/00365513.2021.2003855
Abstract: The use of direct factor Xa inhibitors rivaroxaban and apixaban (XABANs) has rapidly increased; however, there is no validated test available to monitor the effect on hemostasis. This study aims to assess how hemostatic management… read more here.
Keywords: act 120; factor inhibitors; xaban patients; direct factor ... See more keywords